CELC Live signaler | Maksimer profitt med Getagraph.com

KJøP 117275 min ago

@ $15.21

Utstedt: 13 feb 2024 @ 15:42

Avkastning: 16.17%

Forrige signal: feb 9 - 15:30

Forrige signal: Selg

Avkastning: 3.75 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States...

Stats
Dagens volum	282 961
Gjennomsnittsvolum	235 169
Markedsverdi	538.11M
EPS	$0 ( 2024-03-27 )
Neste inntjeningsdato	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.57
ATR14	$0.0590 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Sullivan Brian F.	Sell	45 025	Common Stock
2024-04-26	Sullivan Brian F.	Buy	45 025	Common Stock
2024-04-24	Buller Richard E	Sell	350	Common Stock
2024-04-08	Buller Richard E	Buy	19 558	Stock Option (right to buy)
2024-04-08	Buller Richard E	Buy	12 654	Stock Option (right to buy)

INSIDER POWER
8.72
Last 100 transactions
Buy: 4 121 398 \| Sell: 3 000 264

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: 0.59 (weak)

Signal:(58.226) Neutral

Celcuity Inc Korrelasjon

10 Mest positive korrelasjoner
NICE	0.919
LNW	0.91
NOTV	0.906
CROX	0.904
DVOL	0.895
PCAR	0.895
BRKR	0.895
CPRT	0.894
DAX	0.892
EBIZ	0.892

10 Mest negative korrelasjoner
NH	-0.872
IRDM	-0.846
VORB	-0.841
DCRC	-0.841
PEAR	-0.84
DPRO	-0.84
LAWS	-0.836
SABR	-0.835
TCFC	-0.834
PYR	-0.834

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Celcuity Inc Korrelasjon - Valuta/Råvare

-0.61
( weak negative )

-0.50
( neutral )

0.00
( neutral )

-0.68
( moderate negative )

-0.47
( neutral )

0.64
( weak )

Celcuity Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-142 772 (0.00 %)
EPS:	$-2.69

FY	2023
Omsetning:	$0
Bruttogevinst:	$-142 772 (0.00 %)
EPS:	$-2.69

FY	2022
Omsetning:	$0
Bruttogevinst:	$-210 918 (0.00 %)
EPS:	$-2.68

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.88

Financial Reports:

No articles found.

Celcuity Inc

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.